Cargando…
Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer
SIMPLE SUMMARY: Salivary gland cancer is rare and there is a need to develop new and effective drug therapies. New drugs are in development in the recurrent and metastatic setting that target specific changes within a cancer, some of which can be detected through sequencing of the cancer DNA. This s...
Autores principales: | Rack, Samuel, Feeney, Laura, Hapuarachi, Brindley, Adderley, Helen, Woodhouse, Laura, Betts, Guy, Burghel, George J., Harrington, Kevin J., Metcalf, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909363/ https://www.ncbi.nlm.nih.gov/pubmed/35267442 http://dx.doi.org/10.3390/cancers14051133 |
Ejemplares similares
-
Durable complete response rates following radiotherapy and immunotherapy combination in recurrent and metastatic head and neck squamous cell carcinoma: A retrospective single‐centre cohort study
por: Khera, Raj, et al.
Publicado: (2022) -
Clinical Utility of Quantitative Parameters of Salivary Gland Scintigraphy for Diagnosing Burning Mouth Syndrome
por: Byeon, Hyung Kwon, et al.
Publicado: (2022) -
Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction
por: Tin, Sim Sai, et al.
Publicado: (2015) -
An Unusual Hybrid Salivary Gland Tumor: Molecular Analysis Informs the Potential Pathogenesis of This Rare Neoplasm
por: Zhou, Yan, et al.
Publicado: (2019) -
Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes
por: Hanania, Alexander N., et al.
Publicado: (2021)